Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryonic Medical is a French medical device company focused on NeuroCryoStimulation, a cryotherapy approach that uses pressurized carbon dioxide at approximately -78°C to create rapid thermal shock at the skin surface. The company designs, manufactures, and sells handheld and mobile cryotherapy systems used for pain relief, anti-inflammatory treatment, muscle relaxation, and vascular effects in therapeutic, sports medicine, veterinary, and aesthetic settings. Its products are CE Medical and ISO 13485 certified, and the company states that its devices are designed and manufactured exclusively in France. Cryonic Medical appears to operate as a commercial-stage healthcare equipment business rather than a drug-development biotech or pharma company. Public market references also indicate an older listed entity history under Cryonic Medical SA, while the currently operating business is presented on its website as Cryonic Medical SAS in Besançon, France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cryonic Medical.